Botanical species · safety record

Strychnos ignatii

The EFSA Compendium of Botanicals holds 11 constituent measurements for Strychnos ignatii. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Strychnos ignatii P.J. Bergius

11Constituent measurements
0Safety records
5Cited sources
12Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 12 licensed products naming Strychnos ignatii as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

  • Dried ripe seeds
  • New material
  • Seed(s)
  • Semen

What the records describe

Constituents measured

  • Brucine4
  • Strychnine4
  • Alkaloids3

Plant parts

  • Seed6
  • Bark3
  • Roots and other underground parts1
  • Wood1

Preparations

  • Solvent extraction11

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
AlkaloidsWoodSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
AlkaloidsBarkSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
AlkaloidsRoots and other underground partsSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
BrucineBarkSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
StrychnineBarkSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
BrucineSeedSolvent extraction0.699 PercentStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
BrucineSeedSolvent extraction≥ 0.35 PercentHPLC-DADNo resolvable identifier
BrucineSeedSolvent extraction≤ 0.67 PercentHPLC-DADNo resolvable identifier
StrychnineSeedSolvent extraction≤ 1.77 PercentHPLC-DADNo resolvable identifier
StrychnineSeedSolvent extraction2.811 PercentStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
StrychnineSeedSolvent extraction≥ 0.84 PercentHPLC-DADNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Biala, R. Gadi., Tits, M., Wauters, J.-N., Angenot, L. A new HPLC method for the assay of alkaloids in Strychnos nux-vomica and Strychnos ignatii . Fitoterapia, 1996, vol. 67, no. 2, p. 163-165.
  2. BISSET, NG., WALKER, MD. ALKALOIDS FROM STEM BARK OF STRYCHNOS-IGNATII. Phytochemistry, 1974, vol. 13, no. 2, p. 525-526. DOI
  3. Dhalwal, Kamlesh., Shinde, Vaibhav M., Namdeo, Ajay G., Mahadlik, Kakasaheb R., Kadam, Shivajirao. S. Development and validation of a TLC-Densitometric method for the simultaneous quantitation of strychnine and brucine from Strychnos spp. and its formulations . Journal of chromatographic science, 2007, vol. 45, no. 10, p. 706-709.
  4. DATTA, B., BISSET, NG. ALKALOIDS OF STRYCHNOS-IGNATII. Planta medica, 1990, vol. 56, no. 1, p. 133-133. DOI
  5. MASSIOT, G., ZECHES, M., MIRAND, C., LEMENOLIVIER, L., DELAUDE, C., BASER, KHC., BAVOVADA, R., BISSET, NG., HYLANDS, PJ., STROMBOM, J., VERPOORTE, R. OCCURRENCE OF LONGICAUDATINE, A NEW TYPE OF BIS-INDOLE BASE AND BISNOR-C-ALKALOID-H IN STRYCHNOS SPECIES . Journal of organic chemistry, 1983, vol. 48, no. 11, p. 1869-1872. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue